Zacks Research Downgrades Haleon (NYSE:HLN) to Strong Sell

Haleon (NYSE:HLN) was downgraded by stock analysts at Zacks Research from a “hold” rating to a “strong sell” rating in a report issued on Tuesday,Zacks.com reports.

Several other research analysts have also recently weighed in on the stock. Deutsche Bank Aktiengesellschaft restated a “sell” rating on shares of Haleon in a report on Thursday, April 30th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Haleon in a report on Tuesday, June 30th. Wall Street Zen upgraded Haleon from a “hold” rating to a “buy” rating in a report on Sunday, July 12th. Finally, Rothschild & Co Redburn downgraded Haleon from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, June 16th. Two research analysts have rated the stock with a Strong Buy rating, three have given a Buy rating, three have issued a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, Haleon currently has an average rating of “Moderate Buy”.

Haleon Trading Down 0.7%

NYSE:HLN opened at $9.86 on Tuesday. The firm’s fifty day moving average is $9.33 and its 200-day moving average is $9.85. Haleon has a 52 week low of $8.65 and a 52 week high of $11.28. The company has a debt-to-equity ratio of 0.47, a quick ratio of 0.71 and a current ratio of 0.92. The firm has a market cap of $43.41 billion, a P/E ratio of 25.27, a P/E/G ratio of 2.29 and a beta of 0.13.

Institutional Investors Weigh In On Haleon

Several institutional investors have recently added to or reduced their stakes in HLN. Western Wealth Management LLC purchased a new stake in shares of Haleon during the 1st quarter valued at approximately $29,000. Parkside Financial Bank & Trust boosted its holdings in shares of Haleon by 101.3% in the fourth quarter. Parkside Financial Bank & Trust now owns 2,847 shares of the company’s stock worth $29,000 after acquiring an additional 1,433 shares during the period. Annis Gardner Whiting Capital Advisors LLC grew its position in shares of Haleon by 402.0% in the first quarter. Annis Gardner Whiting Capital Advisors LLC now owns 3,002 shares of the company’s stock valued at $30,000 after purchasing an additional 2,404 shares in the last quarter. Geneos Wealth Management Inc. raised its stake in shares of Haleon by 33.0% during the 1st quarter. Geneos Wealth Management Inc. now owns 4,846 shares of the company’s stock valued at $50,000 after purchasing an additional 1,203 shares during the period. Finally, Caitong International Asset Management Co. Ltd raised its stake in shares of Haleon by 428.1% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 6,321 shares of the company’s stock valued at $57,000 after purchasing an additional 5,124 shares during the period. 6.67% of the stock is owned by hedge funds and other institutional investors.

About Haleon

Haleon plc (NYSE:HLN) is a global consumer healthcare company formed through the separation of a large pharmaceutical group’s consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over‑the‑counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self‑care and symptom relief.

The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.